UFP Technologies/$UFPT
UFP Technologies shares fall as investors weigh a cautious Q3 outlook, with a recent preview flagging expected sequential moderation in sales and earnings, higher overheads and petroleum-linked input-cost pressure.
1 hour agoLightyear AI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About UFP Technologies
UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.
- Ticker
- $UFPT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 4,846
- Headquarters
- Newburyport, United States
- Website
- www.ufpt.com
UFP Technologies Metrics
BasicAdvanced
$2.3B
31.71
$9.25
1.06
-
Price and volume
Market cap
$2.3B
Beta
1.06
52-week high
$338.71
52-week low
$173.86
Average daily volume
109K
Financial strength
Current ratio
3
Quick ratio
1.614
Long term debt to equity
0.258
Total debt to equity
0.295
Interest coverage (TTM)
12.38%
Profitability
EBITDA (TTM)
115.842
Gross margin (TTM)
28.50%
Net profit margin (TTM)
11.45%
Operating margin (TTM)
15.23%
Effective tax rate (TTM)
18.44%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
9.13%
Return on equity (TTM)
17.05%
Valuation
Price to earnings (TTM)
31.711
Price to revenue (TTM)
3.585
Price to book
4.91
Price to tangible book (TTM)
17.36
Price to free cash flow (TTM)
36.871
Free cash flow yield (TTM)
2.71%
Free cash flow per share (TTM)
7.955
Growth
Revenue change (TTM)
7.32%
Earnings per share change (TTM)
7.34%
3-year revenue growth (CAGR)
17.84%
10-year revenue growth (CAGR)
16.20%
3-year earnings per share growth (CAGR)
12.82%
10-year earnings per share growth (CAGR)
24.54%
What the Analysts think about UFP Technologies
Analyst ratings (Buy, Hold, Sell) for UFP Technologies stock.
Analyst projections of the future price of UFP Technologies stock.
Bulls say / Bears say
UFP Technologies delivered record second-quarter sales of $174.0 million, up 15.1%, while net income rose 21.4%. Organic sales growth was 12.4%, showing that the advance was not just acquisition-led. (UFP Technologies)
Growth reached beyond the biggest accounts: MedTech sales outside the top five customers rose 19.7% in the quarter, against 14.7% growth among the top five. That points to wider demand across its customer base. (UFP Technologies)
UFP expects its new robotic-assisted surgery programmes to make an eight-figure contribution in 2027 as production ramps. If those launches meet expectations, they could add a meaningful growth driver beyond current sales. (The Motley Fool)
Two customers generated 25.5% and 21.5% of first-half sales, leaving results exposed to a reduction in orders from either account. The company also flags the risk that its largest customer could make products itself or switch suppliers. (SEC)
Second-quarter SG&A rose 21.8%, faster than sales growth of 15.1%, and increased to 13.1% of sales from 12.4%. Management said delayed programme transfers to the Dominican Republic are also causing near-term mix and margin pressure in US operations. (UFP Technologies)
Cash from operations fell to $18.8 million in the first half from $39.1 million a year earlier, as receivables and inventory absorbed more cash. Continued working-capital demands could constrain funds for capacity investment or acquisitions. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 30 Oct 2026.
UFP Technologies Financial Performance
Revenues and expenses
UFP Technologies Earnings Performance
Company profitability
Upcoming events
No upcoming events
UFP Technologies News
AllArticlesVideos
UFP Technologies to Report Third Quarter 2026 Financial Results on November 3, 2026
Business Wire1 day ago
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds
MarketBeat2 months ago
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
Business Wire2 months ago
Funds containing UFP Technologies
Fund name | Fund size | $UFPT weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.13% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.13% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.07% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.07% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.05% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.